Growth Metrics

Quest Diagnostics (DGX) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $902.0 million.

  • Quest Diagnostics' Consolidated Net Income rose 8.66% to $251.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $986.0 million, marking a year-over-year increase of 13.59%. This contributed to the annual value of $902.0 million for FY2024, which is 2.27% up from last year.
  • According to the latest figures from FY2024, Quest Diagnostics' Consolidated Net Income is $902.0 million, which was up 2.27% from $882.0 million recorded in FY2023.
  • In the past 5 years, Quest Diagnostics' Consolidated Net Income ranged from a high of $2.0 billion in FY2021 and a low of $882.0 million during FY2023.
  • For the 3-year period, Quest Diagnostics' Consolidated Net Income averaged around $918.3 million, with its median value being $902.0 million (2024).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first surged by 7,020.00% in 2020, then slumped by 51.50% in 2022.
  • Yearly analysis of 5 years shows Quest Diagnostics' Consolidated Net Income stood at $1.4 billion in 2020, then soared by 40.59% to $2.0 billion in 2021, then tumbled by 51.50% to $971.0 million in 2022, then fell by 9.17% to $882.0 million in 2023, then climbed by 2.27% to $902.0 million in 2024.